B. Katchen

发表

Importance of dissolution rates in producing effective diazoxide blood levels in man.

B. Calesnick, B. Katchen, J. Black, 1965, Journal of pharmaceutical sciences.

Percutaneous penetration and metabolism of topical (14C)flutamide in men.

B. Katchen, S. Dancik, G. Millington, 1976, The Journal of investigative dermatology.

Disposition of a New, Nonsteroid, Antiandrogen, α,α,α-Trifluoro-2-methyl-4′-nitro-m-propionotoluidide (Flutamide), in Men Following a single Oral 200 mg Dose

B. Katchen, S. Buxbaum, 1975 .

Griseofulvin absorption in man after single and repeated treatment and ts correlation with dissolution rates.

S. Symchowicz, B. Katchen, 1968, Journal of pharmaceutical sciences.

Correlation of dissolution rate and griseofulvin absorption in man.

S. Symchowicz, B. Katchen, 1967, Journal of pharmaceutical sciences.

Metabolism and pharmacokinetics of a new nonsteroid, anti-inflammatory agent, 2-(3-chloro-o-toluidino) nicotinic acid (clonixin) in rats, dogs and monkeys.

J. Meyer, B. Katchen, S. Buxbaum, 1973, The Journal of pharmacology and experimental therapeutics.

Incorporation of glycine-2-C14 into homologous antibody by rabbit tissue slices.

B. Katchen, A. Keston, Bernard Katchen, 1956, Journal of immunology.

Disposition of clonixin (2-(3-chloro-o-toluidino) nicotinic acid) in humans.

B. Katchen, S. Buxbaum, J. Ning, 1973, The Journal of pharmacology and experimental therapeutics.

Maternal and Fetal Hemodynamic Effects of Diazoxide

B. Nuwayhid, C. Brinkman, N. Assali, 1975, Obstetrics and Gynecology.

Correlation of dissolution rate and drug absorption in man.

B. Katchen, 2009, Acta pharmacologica et toxicologica.